The Scientist

» degenerative eye disease

Most Recent

image: The Bionic Eye

The Bionic Eye

By | October 1, 2014

Using the latest technologies, researchers are constructing novel prosthetic devices to restore vision in the blind.

0 Comments

image: Week in Review: March 24–28

Week in Review: March 24–28

By | March 28, 2014

Synthetic yeast chromosome; human enhancers and promoters mapped; brain-wide map links fly behaviors to neurons; treating eye diseases with nanotechnology

0 Comments

image: Smarter Contacts, No More Needles

Smarter Contacts, No More Needles

By | March 26, 2014

Nanotechnology could transform the way clinicians treat eye diseases.

0 Comments

image: Next Generation: Photoswitch Chemical Restores Sight

Next Generation: Photoswitch Chemical Restores Sight

By | February 19, 2014

In blind mice, a light-stimulated small molecule temporarily confers photosensitivity to retinal ganglion cells despite rod and cone damage.

0 Comments

image: Genes Get in Your Eye

Genes Get in Your Eye

By | June 12, 2013

Directed evolution of a gene therapy virus vector improves its penetration into the retina.

5 Comments

image: Restoring Sight

Restoring Sight

By | August 13, 2012

A strategy to transmit signals to retinal nerve cells may show promise as a step toward alternative retinal prosthesis design.

0 Comments

Popular Now

  1. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  2. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. EPO Revokes Broad’s CRISPR Patent
    The Nutshell EPO Revokes Broad’s CRISPR Patent

    Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.

AAAS